NEUROLOGY 2004;63:179-180
© 2004 American Academy of Neurology
Brief Communications
Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy
P. Corcia, MD PhD,
D. Barbereau, MD,
A. M. Guennoc, MD,
B. de Toffol, MD PhD and
Y. Bacq, MD
From the Department of Neurology (Drs. Corcia, Guennoc, and de Toffol), CHRU Bretonneau, and Department of Hepatogastroenterology (Drs. Barbereau and Bacq), CHRU Trousseau, Tours, France.
Address correspondence and reprint requests to Dr. P. Corcia, Service de Neurologie, CHRU Bretonneau, 2 bis Boulevard Tonnellé, 37044 Tours Cedex, France; e-mail: corcia{at}med.univ-tours.fr
A 57-year-old man with chronic inflammatory demyelinating polyneuropathy associated with hepatitis C virus infection was treated successfully with the combination of peginterferon- -2b and ribavirin. Viral eradication was confirmed during the 4th week of treatment and was followed 3 weeks later by neurologic improvement. The patient resumed normal activity 1 year after the therapy was completed.
Received November 20, 2003.
Accepted in final form February 23, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
R. Hoftberger, F. Garzuly, H.P. Dienes, J. Grubits, B. Rohonyi, G. Fischer, Z. Hanzely, H. Lassmann, and H. Budka
Fulminant central nervous system demyelination associated with interferon-{alpha} therapy and hepatitis C virus infection
Multiple Sclerosis,
November 1, 2007;
13(9):
1100 - 1106.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Briani, L. Chemello, G. Zara, M. Ermani, E. Bernardinello, S. Ruggero, E. Toffanin, A. Gatta, L. Battistin, and L. Cavalletto
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV.
Neurology,
September 12, 2006;
67(5):
781 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|